Maximus (NYSE:MMS) Issues Earnings Results, Beats Estimates By $0.22 EPS

Maximus (NYSE:MMS) released its earnings results on Thursday. The health services provider reported $1.61 earnings per share for the quarter, beating analysts’ consensus estimates of $1.39 by $0.22, Zacks reports. Maximus had a net margin of 5.78% and a return on equity of 20.95%. Maximus updated its FY 2025 guidance to 5.900-6.200 EPS.

Maximus Stock Down 1.3 %

Maximus stock traded down $0.91 during mid-day trading on Friday, reaching $69.09. The stock had a trading volume of 424,338 shares, compared to its average volume of 690,485. The company has a market capitalization of $3.95 billion, a price-to-earnings ratio of 13.84 and a beta of 0.72. The company has a 50-day moving average price of $74.83 and a two-hundred day moving average price of $83.53. Maximus has a one year low of $68.30 and a one year high of $93.97. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.49 and a quick ratio of 1.49.

Maximus Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 28th. Shareholders of record on Saturday, February 15th will be given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.74%. The ex-dividend date is Friday, February 14th. Maximus’s payout ratio is currently 24.00%.

Insider Buying and Selling at Maximus

In other Maximus news, Director Raymond B. Ruddy bought 3,490 shares of the firm’s stock in a transaction dated Thursday, December 12th. The stock was acquired at an average cost of $71.46 per share, for a total transaction of $249,395.40. Following the completion of the transaction, the director now owns 112,520 shares in the company, valued at $8,040,679.20. This trade represents a 3.20 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Michelle F. Link sold 2,208 shares of Maximus stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $73.83, for a total value of $163,016.64. Following the completion of the transaction, the insider now owns 6,567 shares in the company, valued at $484,841.61. This trade represents a 25.16 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have purchased 7,063 shares of company stock worth $502,017. Company insiders own 1.60% of the company’s stock.

Analysts Set New Price Targets

Several analysts have weighed in on MMS shares. Raymond James upgraded shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price objective for the company in a research note on Thursday, January 2nd. StockNews.com upgraded shares of Maximus from a “hold” rating to a “buy” rating in a research report on Thursday.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.